Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Test Developed For Early Detection Of Lyme Disease

By LabMedica International staff writers
Posted on 12 May 2016
A new test for early detection of Lyme disease (borreliosis) is being developed and this will improve the ability to detect an active infection more easily than before so that healthy people with Lyme disease antibodies in their blood do not receive unnecessary antibiotic treatment and so that appropriate treatments can be initiated at an early stage.

The current test is only able to analyze part of the human immune system, namely the B-cells but not the T-cells, which are needed as helper cells to fight the infection and whose activity indicates the presence of an infection. More...
The antibody tests that are currently available only provide a reliable result three to four weeks after infection has occurred.

Immunologists at the Medical University of Vienna (Austria) are developing the world's first point-of-care test, which could be used to detect an active infection so that patients could start the appropriate treatment. The test, which is known as the "Ixodes Kit" should be in clinical use in the autumn of 2016, said the scientists, speaking on the occasion of World Immunology Day 2016. Ixodes is the scientific name for hard-bodied ticks that transmit the disease.

Lyme disease is particularly common in Central Europe and in the Scandinavian countries. As a result of climate change, its area of spread is continuously moving northwards. Tick activity is starting earlier and earlier. In Austria itself, they currently have the best climate for ticks. Every year around 70,000 people in Austria develop Lyme disease after being bitten by a deer tick. Approximately one in every four ticks carries Lyme disease. So-called erythema migrans is a sure sign of infection with tick-borne Lyme disease. However, this only occurs in around one third of patients. If the bacterial infection is not detected in good time it can lead to serious problems such as joint inflammation and even very painful infections of the nerve roots resulting in paralysis or memory loss.

Hannes Stockinger, PhD, a professor and Head of the Institute for Hygiene and Applied Immunology, said, “Unfortunately, the current standard laboratory test is often unable to detect Lyme disease at an early stage of the infection. On top of that, the current test often interprets a mere antibody reaction as an infection and people are treated with antibiotics unnecessarily, because the infection is way in the past or is already completely resolved.” In Europe and Asia, the bacteria Borrelia afzelii and Borrelia garinii are the causes of Lyme disease.

Related Links:
Medical University of Vienna


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Over 100 new epigenetic biomarkers may help predict cardiovascular disease risk (Photo courtesy of 123RF)

Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk

Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.